110 related articles for article (PubMed ID: 2784212)
21. Cytolytic activities of activated macrophages versus paraformaldehyde-fixed macrophages; soluble versus membrane-associated TNF.
Fishman M
Cell Immunol; 1991 Oct; 137(1):164-74. PubMed ID: 1832087
[TBL] [Abstract][Full Text] [Related]
22. The cloned cell line L10A2.J expresses natural cytotoxic activity.
Collins JL; Patek PQ; Lin Y; Cohn M
Cell Immunol; 1986 Nov; 103(1):191-8. PubMed ID: 3492283
[TBL] [Abstract][Full Text] [Related]
23. Natural killer-sensitive targets stimulate production of TNF-alpha but not TNF-beta (lymphotoxin) by highly purified human peripheral blood large granular lymphocytes.
Peters PM; Ortaldo JR; Shalaby MR; Svedersky LP; Nedwin GE; Bringman TS; Hass PE; Aggarwal BB; Herberman RB; Goeddel DV
J Immunol; 1986 Oct; 137(8):2592-8. PubMed ID: 3760569
[TBL] [Abstract][Full Text] [Related]
24. Multiple cytolytic mechanisms displayed by activated human peripheral blood T cell subsets.
Smyth MJ; Norihisa Y; Ortaldo JR
J Immunol; 1992 Jan; 148(1):55-62. PubMed ID: 1345790
[TBL] [Abstract][Full Text] [Related]
25. Enhancement of tumor necrosis factor-induced endothelial cell injury by cycloheximide.
Nolop KB; Ryan US
Am J Physiol; 1990 Aug; 259(2 Pt 1):L123-9. PubMed ID: 2382730
[TBL] [Abstract][Full Text] [Related]
26. Tumor growth in vivo selects for resistance to tumor necrosis factor.
Lattime EC; Stutman O
J Immunol; 1989 Dec; 143(12):4317-23. PubMed ID: 2592776
[TBL] [Abstract][Full Text] [Related]
27. Morphology and lytic mechanisms of interleukin 3-dependent natural cytotoxic cells: tumor necrosis factor as a possible mediator.
Jadus MR; Schmunk G; Djeu JY; Parkman R
J Immunol; 1986 Nov; 137(9):2774-83. PubMed ID: 2428873
[TBL] [Abstract][Full Text] [Related]
28. Anti-CD3 antibody-induced activated killer cells: cytokines as the additional signals for activation of killer cells in effector phase to mediate slow lysis.
Ting CC; Hargrove ME
Cell Immunol; 1991 Jul; 135(2):273-84. PubMed ID: 1828008
[TBL] [Abstract][Full Text] [Related]
29. The involvement of protein tyrosine kinase activity in a tumor necrosis factor resistance mechanism.
Sasaki CY; Patek PQ
Proc Soc Exp Biol Med; 1995 Oct; 210(1):25-32. PubMed ID: 7675795
[TBL] [Abstract][Full Text] [Related]
30. Resistance to the cytolytic action of lymphotoxin and tumor necrosis factor coincides with the presence of gap junctions uniting target cells.
Fletcher WH; Shiu WW; Ishida TA; Haviland DL; Ware CF
J Immunol; 1987 Aug; 139(3):956-62. PubMed ID: 3110292
[TBL] [Abstract][Full Text] [Related]
31. Synergistic effect of tumor necrosis factor-alpha- and diphtheria toxin-mediated cytotoxicity in sensitive and resistant human ovarian tumor cell lines.
Morimoto H; Safrit JT; Bonavida B
J Immunol; 1991 Oct; 147(8):2609-16. PubMed ID: 1918981
[TBL] [Abstract][Full Text] [Related]
32. Guinea pig Kurloff (NK-like) cells mediate TNF-dependent cytotoxic activity: analogy with NC effector cells.
Pouliot N; Maghni K; Sirois P; Rola-Pleszczynski M
Inflammation; 1996 Jun; 20(3):263-80. PubMed ID: 8796380
[TBL] [Abstract][Full Text] [Related]
33. In vivo or in vitro selection for resistance to natural cytotoxic cell lysis selects for variants with increased tumorigenicity.
Patek PQ; Lin Y; Collins JL; Cohn M
J Immunol; 1986 Jan; 136(2):741-5. PubMed ID: 3941271
[TBL] [Abstract][Full Text] [Related]
34. Cycloheximide-induced modulation of TNF-mediated cytotoxicity in sensitive and resistant ovarian tumor cells.
Nio Y; Zighelboim J; Berek J; Bonavida B
Cancer Chemother Pharmacol; 1990; 26(1):1-8. PubMed ID: 2322985
[TBL] [Abstract][Full Text] [Related]
35. Dexamethasone inhibits the cytotoxic activity of tumor necrosis factor.
Tsujimoto M; Okamura N; Adachi H
Biochem Biophys Res Commun; 1988 May; 153(1):109-15. PubMed ID: 3377783
[TBL] [Abstract][Full Text] [Related]
36. Role of TNF-alpha in CD8+ cytotoxic T lymphocyte-mediated lysis.
Ratner A; Clark WR
J Immunol; 1993 May; 150(10):4303-14. PubMed ID: 8482837
[TBL] [Abstract][Full Text] [Related]
37. Transformation is associated with an increase in sensitivity to TNF-mediated lysis as a result of an increase in TNF-induced protein tyrosine phosphatase activity.
Sasaki CY; Patek PQ
Int J Cancer; 1999 Mar; 81(1):141-7. PubMed ID: 10077165
[TBL] [Abstract][Full Text] [Related]
38. Three distinct cell phenotypes of induced-TNF cytotoxicity and their relationship to apoptosis.
Woods KM; Chapes SK
J Leukoc Biol; 1993 Jan; 53(1):37-44. PubMed ID: 8426090
[TBL] [Abstract][Full Text] [Related]
39. Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104.
Brando C; Mukhopadhyay S; Kovacs E; Medina R; Patel P; Catina TL; Campbell KS; Santoli D
J Leukoc Biol; 2005 Aug; 78(2):359-71. PubMed ID: 15937142
[TBL] [Abstract][Full Text] [Related]
40. Resistance of primary CD8+ cytotoxic T lymphocytes to lysis by cytotoxic granules from cloned T cell lines.
Nagler-Anderson C; Verret CR; Firmenich AA; Berne M; Eisen HN
J Immunol; 1988 Nov; 141(10):3299-305. PubMed ID: 2972770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
